Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Neoplasms and MICB[original query] |
|---|
| Associations of MICB with cervical cancer in north-eastern Thais: identification of major histocompatibility complex class I chain-related gene B motifs influencing natural killer cell activation. Clinical and experimental immunology 2008 Aug 153 (2): 205-13. Jumnainsong A, Jearanaikoon P, Khahmahpahte S, Wongsena W, Romphruk A V, Chumworathayi B, Vaeteewoottacharn K, Ponglikitmongkol M, Romphruk A, Leelayuwat |
| MMP9 Promoter Polymorphism (-1562 C/T) Does not Affect the Serum Levels of Soluble MICB and MICA in Breast Cancer. Iranian journal of immunology : IJI 2016 Mar 13 (1): 45-53. Bargostavan Mohammad Hasan, Eslami Gilda, Esfandiari Nasrin, Shams Shahemabadi A |
| High-Throughput MICA/B Genotyping of Over Two Million Samples: Workflow and Allele Frequencies. Frontiers in immunology 2020 3 11 314. Klussmeier Anja, Massalski Carolin, Putke Kathrin, Schäfer Gesine, Sauter Jürgen, Schefzyk Daniel, Pruschke Jens, Hofmann Jan, Fürst Daniel, Carapito Raphael, Bahram Seiamak, Schmidt Alexander H, Lange Vinze |
| Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development. Acta pharmaceutica (Zagreb, Croatia) 2023 6 73 (2): 243-256. Jurica Baranasic, Yasmeen Niazi, Subhayan Chattopadhyay, Lada Rumora, Lorna ?orak, Andrea Vuki? Dugac, Marko Jakopovi?, Miroslav Samaržija, Asta Försti, Jelena Knežev |
| Associations between MICA and MICB genetic variants, protein levels, and colorectal cancer: Atherosclerosis Risk in Communities (ARIC). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 3 . Wang Shuo, Onyeaghala Guillaume C, Pankratz Nathan, Nelson Heather H, Thyagarajan Bharat, Tang Weihong, Norby Faye L, Ugoji Chinenye, Joshu Corinne E, Gomez Christian R, Couper David J, Coresh Josef, Platz Elizabeth A, Prizment Anna |
| Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis. Frontiers in immunology 2023 11 14 1238312. Youwei Yue, Xinyi Cai, Changhao Lu, Leonardo Antonio Sechi, Paolo Solla, Shensuo |
| CTLA4 genetic variants associated with urothelial bladder cancer susceptibility. Urologic oncology 2024 6 . Alexsandro Koike, Andréa Name Colado Simão, Tainah Mendes Ahrens, Kaue de Morais Cardoso, Beatriz Rabello Espinosa, Roberson Henrique Gobanhi Gualberto, Daniel Felipe Piva Santos, Guilherme Lerner Trigo, Edna Maria Vissoci Reiche, Marcell Alysson Batisti Lozov |
| Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 4 . Birgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek, Jade M van Berge Henegouwen, Louisa R Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Joris van de Haar, Annemiek van Ommen-Nijhof, Marleen Kok, Paul Roepman, Anne M L Jansen, Wendy W J de Leng, Maja J A de Jonge, Ann Hoeben, Carla M L van Herpen, Hans M Westgeest, Lodewyk F A Wessels, Henk M W Verheul, Hans Gelderblom, Emile E Voe |
| Causal associations of MICB, CTSA, and MMP9 proteins with oral cancer: Mendelian randomization study. Scientific reports 2024 10 14 (1): 25645. Bowen Dong, Jianlei Hua, Shengxuan Ma, Li Wang, Haotian Xiao, Xianghe Qiao, Rui Zhao, Yiming L |
- Page last reviewed:Feb 1, 2024
- Content source: